Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study Utilizing Rilonacept in Gout Exacerbations (SURGE)

This study has been completed.
Information provided by (Responsible Party):
Regeneron Pharmaceuticals Identifier:
First received: February 13, 2009
Last updated: September 27, 2013
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: January 5, 2011